Salt-induced renal injury in spontaneously hypertensive rats: effects of nebivolol. 2010

Jasmina Varagic, and Sarfaraz Ahmad, and K Bridget Brosnihan, and Javad Habibi, and Roger D Tilmon, and James R Sowers, and Carlos M Ferrario
Hypertension and Vascular Research Center, Wake Forest University, Winston-Salem, NC 27157, USA. jvaragic@wfubmc.edu

BACKGROUND we investigated renal effects of nebivolol, a selective β(1)-receptor blocker with additional antioxidative ability, in spontaneously hypertensive rats (SHR) where increased salt intake induces oxidative stress and worsens renal function as a result of further activation of the renin-angiotensin and sympathetic nervous systems. METHODS male SHR were given an 8% salt diet (HS; n = 22) for 5 weeks; their age-matched controls (n = 9) received standard chow. Nebivolol was given at a dose of 10 mg/kg/day for 5 weeks in 11 HS rats. RESULTS HS increased blood pressure, plasma renin concentration, urinary protein excretion, and renal nitroxidative stress while decreasing renal blood flow and angiotensin 1-7 receptor (mas) protein expression. There was no change in angiotensin II type 1 receptor expression among the experimental groups. Nebivolol did not alter the salt-induced increase in blood pressure but reduced urinary protein excretion, plasma renin concentration, and nitroxidative stress. Nebivolol also increased neuronal NOS expression while preventing the salt-induced decrease in renal blood flow and mas protein expression. CONCLUSIONS nebivolol prevented salt-induced kidney injury and associated proteinuria in SHR through a blood pressure-independent mechanism. Its protective effects may be related to reduction in oxidative stress, increases in neuronal NOS and restoration of angiotensin II type 1/mas receptor balance.

UI MeSH Term Description Entries
D008297 Male Males
D011507 Proteinuria The presence of proteins in the urine, an indicator of KIDNEY DISEASES. Proteinurias
D011518 Proto-Oncogene Proteins Products of proto-oncogenes. Normally they do not have oncogenic or transforming properties, but are involved in the regulation or differentiation of cell growth. They often have protein kinase activity. Cellular Proto-Oncogene Proteins,c-onc Proteins,Proto Oncogene Proteins, Cellular,Proto-Oncogene Products, Cellular,Cellular Proto Oncogene Proteins,Cellular Proto-Oncogene Products,Proto Oncogene Products, Cellular,Proto Oncogene Proteins,Proto-Oncogene Proteins, Cellular,c onc Proteins
D011918 Rats, Inbred SHR A strain of Rattus norvegicus with elevated blood pressure used as a model for studying hypertension and stroke. Rats, Spontaneously Hypertensive,Rats, SHR,Inbred SHR Rat,Inbred SHR Rats,Rat, Inbred SHR,Rat, SHR,Rat, Spontaneously Hypertensive,SHR Rat,SHR Rat, Inbred,SHR Rats,SHR Rats, Inbred,Spontaneously Hypertensive Rat,Spontaneously Hypertensive Rats
D012079 Renal Circulation The circulation of the BLOOD through the vessels of the KIDNEY. Kidney Circulation,Renal Blood Flow,Circulation, Kidney,Circulation, Renal,Blood Flow, Renal,Flow, Renal Blood
D012083 Renin A highly specific (Leu-Leu) endopeptidase that generates ANGIOTENSIN I from its precursor ANGIOTENSINOGEN, leading to a cascade of reactions which elevate BLOOD PRESSURE and increase sodium retention by the kidney in the RENIN-ANGIOTENSIN SYSTEM. The enzyme was formerly listed as EC 3.4.99.19. Angiotensin-Forming Enzyme,Angiotensinogenase,Big Renin,Cryorenin,Inactive Renin,Pre-Prorenin,Preprorenin,Prorenin,Angiotensin Forming Enzyme,Pre Prorenin,Renin, Big,Renin, Inactive
D012084 Renin-Angiotensin System A BLOOD PRESSURE regulating system of interacting components that include RENIN; ANGIOTENSINOGEN; ANGIOTENSIN CONVERTING ENZYME; ANGIOTENSIN I; ANGIOTENSIN II; and angiotensinase. Renin, an enzyme produced in the kidney, acts on angiotensinogen, an alpha-2 globulin produced by the liver, forming ANGIOTENSIN I. Angiotensin-converting enzyme, contained in the lung, acts on angiotensin I in the plasma converting it to ANGIOTENSIN II, an extremely powerful vasoconstrictor. Angiotensin II causes contraction of the arteriolar and renal VASCULAR SMOOTH MUSCLE, leading to retention of salt and water in the KIDNEY and increased arterial blood pressure. In addition, angiotensin II stimulates the release of ALDOSTERONE from the ADRENAL CORTEX, which in turn also increases salt and water retention in the kidney. Angiotensin-converting enzyme also breaks down BRADYKININ, a powerful vasodilator and component of the KALLIKREIN-KININ SYSTEM. Renin-Angiotensin-Aldosterone System,Renin Angiotensin Aldosterone System,Renin Angiotensin System,System, Renin-Angiotensin,System, Renin-Angiotensin-Aldosterone
D001794 Blood Pressure PRESSURE of the BLOOD on the ARTERIES and other BLOOD VESSELS. Systolic Pressure,Diastolic Pressure,Pulse Pressure,Pressure, Blood,Pressure, Diastolic,Pressure, Pulse,Pressure, Systolic,Pressures, Systolic
D004983 Ethanolamines AMINO ALCOHOLS containing the ETHANOLAMINE; (-NH2CH2CHOH) group and its derivatives. Aminoethanols
D000068577 Nebivolol A cardioselective ADRENERGIC BETA-1 RECEPTOR ANTAGONIST (beta-blocker) that functions as a VASODILATOR through the endothelial L-arginine/ NITRIC OXIDE system. It is used to manage HYPERTENSION and chronic HEART FAILURE in elderly patients. Alpha,Alpha'-(Iminobis(Methylene))bis(6-Fluoro-3,4-dihydro)-2H-1-benzopyran-2-methanol,Bystolic,Lobivon,Nebilet,Nebivolol Hydrochloride,R 67555,R-67555,Silostar,67555, R,Hydrochloride, Nebivolol,R67555

Related Publications

Jasmina Varagic, and Sarfaraz Ahmad, and K Bridget Brosnihan, and Javad Habibi, and Roger D Tilmon, and James R Sowers, and Carlos M Ferrario
January 2009, American journal of nephrology,
Jasmina Varagic, and Sarfaraz Ahmad, and K Bridget Brosnihan, and Javad Habibi, and Roger D Tilmon, and James R Sowers, and Carlos M Ferrario
January 2012, Journal of the American Society of Hypertension : JASH,
Jasmina Varagic, and Sarfaraz Ahmad, and K Bridget Brosnihan, and Javad Habibi, and Roger D Tilmon, and James R Sowers, and Carlos M Ferrario
June 2013, The Journal of international medical research,
Jasmina Varagic, and Sarfaraz Ahmad, and K Bridget Brosnihan, and Javad Habibi, and Roger D Tilmon, and James R Sowers, and Carlos M Ferrario
June 1994, Hypertension (Dallas, Tex. : 1979),
Jasmina Varagic, and Sarfaraz Ahmad, and K Bridget Brosnihan, and Javad Habibi, and Roger D Tilmon, and James R Sowers, and Carlos M Ferrario
January 2006, Journal of hypertension,
Jasmina Varagic, and Sarfaraz Ahmad, and K Bridget Brosnihan, and Javad Habibi, and Roger D Tilmon, and James R Sowers, and Carlos M Ferrario
November 1990, Hypertension (Dallas, Tex. : 1979),
Jasmina Varagic, and Sarfaraz Ahmad, and K Bridget Brosnihan, and Javad Habibi, and Roger D Tilmon, and James R Sowers, and Carlos M Ferrario
May 1999, Hypertension (Dallas, Tex. : 1979),
Jasmina Varagic, and Sarfaraz Ahmad, and K Bridget Brosnihan, and Javad Habibi, and Roger D Tilmon, and James R Sowers, and Carlos M Ferrario
February 1984, Journal of hypertension,
Jasmina Varagic, and Sarfaraz Ahmad, and K Bridget Brosnihan, and Javad Habibi, and Roger D Tilmon, and James R Sowers, and Carlos M Ferrario
January 2011, Physiological research,
Jasmina Varagic, and Sarfaraz Ahmad, and K Bridget Brosnihan, and Javad Habibi, and Roger D Tilmon, and James R Sowers, and Carlos M Ferrario
March 2001, Journal of the renin-angiotensin-aldosterone system : JRAAS,
Copied contents to your clipboard!